{"page_content": "ESG R eport 2020ESG PROGRAM  OBJECTIVES\nOur vision to make the world a better place is foundational to Agios. We are driven to improve the lives of those fighting life-threatening and \nlife-altering diseases, including genetically defined cancers and rare diseases that have often been overlooked or neglected. We have pioneered \ntwo novel therapeutic approaches \u2013 IDH inhibition and PKR activation \u2013 and continue to focus on creating an environment in which scientific \ninnovation on behalf of patients can thrive. Our ESG program is centered around our commitments to:\nPATIENTS07\nOUR COMMUNITIES  \n& WORLD20EMPLOYEES13\nETHICS & VALUES23\nThough our commitments are longstanding, we are proud to launch our inaugural ESG report this year. We look forward to continuing to grow \nour program and build upon these initiatives for years to come.\nPAGE\nPAGE\nPAGE\nPAGE\n4", "metadata": {"source": "NASDAQ_AGIO_2019.pdf", "page": 3, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}